The University of Auckland is hosting the research as part of the Global COVID Vaccine Safety (GCoVS) Project. Scientists ...

Sweeping U.S. policy changes under Health Secretary Robert F. Kennedy Jr. are having a ‌chilling effect ​on vaccine makers as ...

A personalised mRNA vaccine developed by Moderna and Merck shows lasting benefits for patients with high-risk skin cancer.

The unprecedented changes have led to diminished vaccine usage, and created a drag that will likely dent revenues.

Knowable Magazine reports on advancements in pancreatic cancer treatment, including new drugs, vaccines, and early diagnostic ...

A study aimed to compare corneal topographic and specular microscopic parameters both before and after patients received the ...

With $30 million in funding from the Coalition for Epidemic Preparedness Innovations (CEPI), Merck & Co. | The project, which involves Merck, SK Biosciences, Hilleman Laboratories and CDMO IDT ...

Under the terms of the agreement, Pfizer is expected to pay an upfront total of $30 million in early 2026 to Novavax, while ...

German biotech BioNTech today announced that the US Food and Drug Administration (FDA) has granted fast track designation to ...

After a period defined by its COVID-19 vaccine, BioNTech is reasserting its presence in the oncology arena. A recent regulatory milestone and a significant upgrade from a major investment bank are ...

Sweeping changes to U.S. vaccine policy under Health Secretary Robert F. Kennedy Jr. are creating uncertainty across the pharmaceutical sector, dampening investor confidence and raising concerns among ...

Only four months after IO Biotech decided to halve its head count, the Danish biotech is already considering whether it must ...